Skip to main content
SpringerLink
Log in

Systematischer Vergleich der Testverfahren

  • Chapter
BRCA — Erblicher Brust- und Eierstockkrebs

  • 436 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 39.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abbaszadegan MR et al. (1997) Automated detection of prevalent muations in BRCA1 and BRCA2 genes, using a fluorogenic PCR allellic discrimination assay Genet Test 1: 171–180

    CAS  PubMed  Google Scholar 

  • Andrulis IL, Anton-Culver H, Beck J, Bove B, Boyd J, Buys S et al. (2002) Comparison of DNA-and RNAbased methods for detection of truncating BRCA1 mutations. Hum Mutat 20: 65–73.

    Article  CAS  PubMed  Google Scholar 

  • Arnold N, Gross E, Schwarz-Boeger U, Pfisterer J, Jonat W, Kiechle M. (1999) A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers. Hum Mutat 14:333–339.

    Article  CAS  PubMed  Google Scholar 

  • Auer H, Lyianarachchi S, Newsom D, Klisovic MI, Marcucci G, Kornacker K. (2003) Chipping away at the chip bias: RNA degradation in microarray analysis. Nat Genet 35: 292–3. (Letter)

    Article  CAS  PubMed  Google Scholar 

  • Berger SL, Cooper HL. (1975) Very short-lived and stable mRNAs from resting human lymphocytes. Proc Natl Acad Sci USA 72: 3873–7.

    CAS  PubMed  Google Scholar 

  • Bossuyt PM, Reitsman JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM et al. (2003) BMJ 326: 41–44

    Article  PubMed  Google Scholar 

  • BVmedgen und GfH. (1996) Richtlinien und Stellungnahmen: Leitlinien zur molekulargenetischen Labordiagnostik. medgen 8:Bl 4.

    Google Scholar 

  • Casadei S, Cortesi L, Pensotti V et al. (2001) Detection of germline BRCA1 mutations by Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) method. Br J Cancer 85: 845–849.

    Article  CAS  PubMed  Google Scholar 

  • Deeks JJ (2001) Systematic reviews of evaluations of diagnostic and screening tests. In: Egger M, Smith GD, Altman DG (eds) Systematic reviews in health care BMJ Publishing Group, London

    Google Scholar 

  • De Vet HCW, van der Weijden T, Muris JWM, Heyrman J, Buntinx F & Knottnerus JA (2001) Systematic reviews of diagnostic research. Considerations about assessment and incorporation of methodological quality European Journal of Epidemiology 17: 301–306

    PubMed  Google Scholar 

  • Eng C, Brody LC, Wagner TM et al. (2001) Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J Med Genet 38: 824–833.

    Article  CAS  PubMed  Google Scholar 

  • Flynn K, Adams E (1996) Report No 1: Assessing diagnostic technologies Technology Assessment Program Boston, USA

    Google Scholar 

  • Footz T, Somerville MJ, Tomaszewski R, Sprysak KA, Backhouse CA. (2003) Heteroduplex-based genotyping with microchip electrophoresis and DHPLC. Genet Test 7: 283–93.

    Article  CAS  PubMed  Google Scholar 

  • Ganguly T, Dhulipala R, Godmilow L, Ganguly A. (1998) High throughput fluorescence-based conformationsensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families. Hum Genet 102: 549–556.

    Article  CAS  PubMed  Google Scholar 

  • German Consortium for Hereditary Breast and Ovarian Cancer (2002) Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the german population Int J Cancer 97: 472–480

    Google Scholar 

  • Glavac D, Dean M (1993) Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations. Hum Mutat 2(5): 404–14

    CAS  PubMed  Google Scholar 

  • Gordis L (2001) Epidemiologie. Dt. Erstausgabe. Übersetzt von Rau R, Bocter N Kilian, Marburg

    Google Scholar 

  • Gross E, Arnold N, Goette J, Schwarz-Boeger U, Kiechle M. (1999) A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Genet 105: 72–78.

    Article  CAS  PubMed  Google Scholar 

  • Hartmann C, Klaes R, Köhler R, Janssen B, Zschocke J. (2003) Identification of genomic rearrangements in the BRCA1-gene by MLPA-method in cases of familial breast cancer. 14th Annual General Meeting of the German Society of Human Genetics, Marburg, 1–4.10.2003. Abstract P010. medgen 15: 295.

    Google Scholar 

  • Healey CS, Dunning AM, Teare MD et al. (2000) A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet 26: 362–4.

    Article  CAS  PubMed  Google Scholar 

  • Hogervorst FBL, Nederlof PM, Gille JJP et al. (2003) Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 63: 1449–1453.

    CAS  PubMed  Google Scholar 

  • Hopwood P, van Asperen CJ, Legius E et al. (2003) Cancer genetics service provision: a comparison of 7 European centres. Community Genet 6:192–205.

    CAS  PubMed  Google Scholar 

  • Jakubowska A, Gorski B, Byrski T et al. (2001) Detection of germline mutations in the BRCA1 gene by RNAbased sequencing. Hum Mutat 18: 149–156.

    CAS  PubMed  Google Scholar 

  • King DJ, Noss RR. (1989) Toxicity of polyacrylamide and acrylamide monomer. Rev Environ Health 8: 3–16.

    CAS  PubMed  Google Scholar 

  • Knottnerus JA, van Weel C, Muris JWM (2002) Evaluation of diagnostic procedures BMJ 324: 477–480

    Article  PubMed  Google Scholar 

  • Kringen P, Egedal S, Pedersen JC et al. (2002) BRCA1 mutation screening using restriction endonuclease fingerprinting-single-strand conformation polymorphism in an automated capillary electrophoresis system. Electrophoresis 23: 4085–4091.

    Article  CAS  PubMed  Google Scholar 

  • Lijmer JG, Mol BW, Heisterkamp S et al. (1999) Empirical evidence of design-related bias in studies of diagnostic tests JAMA 282: 1061–1066

    Article  CAS  PubMed  Google Scholar 

  • Lu M, Conzen SD, Cole CN, Arrick BA. (1996) Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells. Cancer Res 56: 4578–81.

    CAS  PubMed  Google Scholar 

  • Maekawa M, Nagaoka T, Taniguchi T et al. (2004) Three-dimensional microarray compared with PCR-singlestrand conformation polymorphism analysis and DNA sequencing for mutation analysis of K-ras codons 12 and 13. Clin Chem Jun 3 [Epub ahead of print].

    Google Scholar 

  • Miki Y, Swensen J, Shattuck-Eidens D, et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71.

    CAS  PubMed  Google Scholar 

  • Moore W et al. (2000) Mutation detection in the breast cancer gene BRCA1 using the protein truncation test Mol Biotechnol 14: 89–97

    Article  CAS  PubMed  Google Scholar 

  • NICE (2004) NICE Clinical Guideline 14: Familial breast cancer. The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. National Institute for Clinical Excellence, London.

    Google Scholar 

  • Pals G, Pindolia K, Worsham MJ. (1999) A rapid and sensitive approach to mutation detection using real-time polymerase chain reaction and melting curve analyses, using BRCA1 as an example. Mol Diagn 4: 241–6.

    CAS  PubMed  Google Scholar 

  • Petrij-Bosch A, Peelen T, van Vliet M et al. (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17: 341–5.

    CAS  PubMed  Google Scholar 

  • Puget N, Torchard D, Serova-Sinilnikova OM, Lynch HT, Feunteun J, Lenoir GM, Mazoyer S. (1997) A 1-kb Alu-mediated germline deletion removing BRCA1 exon 17. Cancer Res 57: 828–3

    CAS  PubMed  Google Scholar 

  • Rothfuss A, Schutz P, Bochum S et al. (2000) Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. [see comment]. Cancer Res. 60: 390–394.

    CAS  PubMed  Google Scholar 

  • Sackett DL, Haynes RB (2002) The architecture of diagnostic research BMJ 324: 539–541

    Article  CAS  PubMed  Google Scholar 

  • Sakayori M, Kawahara M, Shiraishi K et al. (2003) Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1and BRCA2genes in familial breast cancer. J Hum Genet 48: 130–137.

    CAS  PubMed  Google Scholar 

  • Sevilla C, Julian-Reynier C, Eisinger F et al. (2003) Impact of gene patents on the cost-effective delivery of care: the case of BRCA1 genetic testing International Journal of Technology Assessment in Health Care 19: 287–300

    Article  PubMed  Google Scholar 

  • Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM. (1993) The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 16(2): 325–32

    Article  CAS  PubMed  Google Scholar 

  • Suh Y (2001) CSNP discovery by two-dimensional gene scanning (TDGS) [Koreanisch] Exp Mol Med 33(Suppl. 1): 21–47

    CAS  PubMed  Google Scholar 

  • Surralles J, Natarajan AT. (1997) Human lymphocytes micronucleus assay in Europe. An international survey. Mutat Res 392: 165–74.

    CAS  PubMed  Google Scholar 

  • Wagner T, Stoppa-Lyonnet D, Fleischmann E et al. (1999) Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics 62: 369–376.

    Article  CAS  PubMed  Google Scholar 

  • Wagner E, Lykke-Andersen. (2002) mRNA surveillance: the perfect persist. J Cell Sci 115: 3033–38.

    CAS  PubMed  Google Scholar 

  • Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 379: 789–92.

    Google Scholar 

  • Wormington M. (2003) Zero tolerance for nonsense: nonsense-mediated mRNA decay uses multiple degradation pathways. Mol Cell 12: 536–8. Review.

    Article  CAS  PubMed  Google Scholar 

Eingeschlossene Literatur

  1. [1]_Andrulis IL, Anton-Culver H, Beck J et al. (2002)Comparison of DNA-and RNA-based methods for detection of truncating BRCA1 mutations. Hum Mutat 20: 65–73.

    Article  CAS  PubMed  Google Scholar 

  2. [2]_Arnold N, Gross E, Schwarz-Boeger U, Pfisterer J, Jonat W, Kiechle M. (1999) A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers. Hum Mutat 14:333–339.

    Article  CAS  PubMed  Google Scholar 

  3. [3]_Casadei S, Cortesi L, Pensotti V et al. (2001) Detection of germline BRCA1 mutations by Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) method. Br J Cancer 85: 845–849.

    Article  CAS  PubMed  Google Scholar 

  4. [4]_Eng C, Brody LC, Wagner TM et al. (2001) Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J Med Genet 38: 824–833.

    Article  CAS  PubMed  Google Scholar 

  5. [5]_Ganguly T, Dhulipala R, Godmilow L, Ganguly A. (1998) High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families. Hum Genet 102:549–556.

    Article  CAS  PubMed  Google Scholar 

  6. [6]_Gross E, Arnold N, Goette J, Schwarz-Boeger U, Kiechle M. (1999) A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Genet 105: 72–78.

    Article  CAS  PubMed  Google Scholar 

  7. [7]_Jakubowska A, Gorski B, Byrski T et al. (2001) Detection of germline mutations in the BRCA1 gene by RNA-based sequencing. Hum Mutat 18: 149–156.

    CAS  PubMed  Google Scholar 

  8. [8]_Kringen P, Egedal S, Pedersen JC et al. (2002) BRCA1 mutation screening using restriction endonuclease fingerprinting-single-strand conformation polymorphism in an automated capillary electrophoresis system. Electrophoresis 23: 4085–4091.

    Article  CAS  PubMed  Google Scholar 

  9. [9]_Rothfuss A, Schutz P, Bochum S et al. (2000) Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. [see comment]. Cancer Res. 60: 390–394.

    CAS  PubMed  Google Scholar 

  10. [10]_Sakayori M, Kawahara M, Shiraishi K et al. (2003) Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1and BRCA2genes in familial breast cancer. J Hum Genet 48: 130–137.

    CAS  PubMed  Google Scholar 

HTA-Berichte und Leitlinien

  • Noorani HZ, McGahan L. (1999) Predictive genetic testing for breast and prostate cancer. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA).

    Google Scholar 

  • ITA (2002) Prädiktive humangenetische Diagnostik bei hereditärem Mamma-und Kolorektalkarzinom: Ein Assessment. Institut für Technikfolgenabschätzung, Wien

    Google Scholar 

  • Ho C, Banerjee S, Mensinkai S. (2003) Molecular diagnosis for hereditary cancer predisposing syndromes: genetic testing and clinical impact. Ottawa: Canadian Coordinating Office for Health Technology Assessment; Technology report no 41.

    Google Scholar 

  • NICE (2004) NICE Clinical Guideline 14: Familial breast cancer. The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. National Institute for Clinical Excellence, London.

    Google Scholar 

Primärstudien

  • Andersen TI, Eiken HG, Couch F et al. (1998) Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening. Hum Mutat 11: 166–174. Kein (vollständiger) Vergleich mit Referenztest

    Article  CAS  PubMed  Google Scholar 

  • Arnold N, Gross E, Schwarz BU, Pfisterer J, Jonat W, Kiechle M. (1999) A fast, highly sensitive and cheap tool for mutation analysis of complex genes. Dis Markers 15: 118 keine Studie

    Google Scholar 

  • Barker DF. (2000) Direct genomic multiplex PCR for BRCA1 and application to mutation detection by singlestrand conformation and heteroduplex analysis. Hum Mutat 16: 334–344. Keine Kontrollgruppe

    Article  CAS  PubMed  Google Scholar 

  • Barrois MB. (2004) Real-time PCR-based gene dosage assay for detecting BRCA1 rearrangements in breastovarian cancer families. Clin Genet 65: 131–136. Große Sequenzrearrangements

    Article  CAS  PubMed  Google Scholar 

  • Bateman JF, Freddi S, Lamande SR et al. (1999) Reliable and sensitive detection of premature termination mutations using a protein truncation test designed to overcome problems of nonsense-mediated mRNA instability. Hum Mutat 13: 311–317. Nicht BRCA-Gen

    Article  CAS  PubMed  Google Scholar 

  • Bazar LS, Collier GB, Vanek PG et al. (1999) Mutation identification DNA analysis system (MIDAS) for detection of known mutations. Electrophoresis 20: 1141–1148. Nur einzelne Mutationen

    Article  CAS  PubMed  Google Scholar 

  • Bazar LS, Hartmann DP, Cunningham RP, Chirikjian JG, Collier GB. (1997) OsCAR as a rapid DNA diagnostic test for BRCA1 mutations. Proceedings of the American Association for Cancer Research Annual Meeting 38: 234. Keine Studie

    Google Scholar 

  • Bergman A, Engwall Y, Lundberg J et al. (2003) Mutation spectrum of the BRCA1 and BRCA2 genes in western Sweden. Am J Hum Genet 73(5): 232 Keine Studie

    Google Scholar 

  • Bernstein JL, Thompson WD, Casey G et al. (2002) Comparison of techniques for the successful detection of BRCA1 mutations in fixed paraffin-embedded tissue. Cancer Epidemiol Biomarkers Prev; 11: 809–814. Keine Kontrollgruppe

    CAS  PubMed  Google Scholar 

  • Betz B, Ruhl D, Du M, Goecke T, Nestle KC, Niederacher D. (2002) Mutation detection by DHPLC (denaturing high-performance liquid chromatography) in familial and sporadic breast cancer. Proceedings of the American Association for Cancer Research Annual Meeting 43: 993. Keine Studie

    Google Scholar 

  • Blesa JR, Hernandez-Yago J. (2000) Adaptation of conformation-sensitive gel electrophoresis to an ALFexpress DNA sequencer to screen BRCA1 mutations. Biotechniques 28: 1019–1025. Keine Kontrollgruppe

    CAS  PubMed  Google Scholar 

  • Bounpheng M, McGrath S, Macias D et al. (2003) Rapid, inexpensive scanning for all possible BRCA1 and BRCA2 gene sequence variants in a single assay: implications for genetic testing. J Med Genet 40: e33. Kein (vollständiger) Vergleich mit Referenztest

    Article  CAS  PubMed  Google Scholar 

  • Byrne TJ, Reece MT, Adams LA, Hoffman DE, Lane MA, Cohn GM. (2000) A rapid immunoassay predicts BRCA1 and BRCA2 mutations in buccal cells. Oncol Rep 7: 1203–1207. Kein (vollständiger) Vergleich mit Referenztest

    CAS  PubMed  Google Scholar 

  • Byrne TJ, Reece MT, Adams LA, Lane MA, Cohn GM. (2000) An antibody assay predictive of BRCA1 mutations in ovarian tumors and normal tissue. Oncol Rep 7(5): 949–953. Kein (vollständiger) Vergleich mit Referenztest

    CAS  PubMed  Google Scholar 

  • Campos B, Diez O, Cortes J et al. (2001) Conditions for single-strand conformation polymorphism (SSCP) analysis of BRCA1 gene using an automated electrophoresis unit. CLIN CHEM LAB MED 39: 401–404. Nur einzelne Mutationen

    Article  CAS  PubMed  Google Scholar 

  • Casilli F, Di Rocco ZC, Gad S et al. (2002) Rapid detection of novel BRCA1 rearrangements in high-risk breastovarian cancer families using multiplex PCR of short fluorescent fragments. Hum Mutat 20: 218–226. Große Sequenzrearrangements

    Article  CAS  PubMed  Google Scholar 

  • Chan PC, Wong BY, Ozcelik H, Cole DE. (1999) Simple and rapid detection of BRCA1 and BRCA2 mutations by multiplex mutagenically separated PCR. Clin Chem 45: 1285–1287. Nur einzelne Mutationen

    CAS  PubMed  Google Scholar 

  • Chen J, Hebert PD. (1998) Directed termination PCR: a one-step approach to mutation detection. Nucleic Acids Res. 26: 1546–1547. Keine Studie

    CAS  PubMed  Google Scholar 

  • Cheung P, Chan R, Wong BYL, Ozcelik H, Cole DEC. (1999) Simple and rapid detection of BRCA1 and BRCA2 mutations by multiplex mutagenically separated PCR. Clin Chem. 45: 8–1287. Nur einzelne Mutationen

    Google Scholar 

  • Consolandi C, Castiglioni B, Bordoni R et al. (2002) Two efficient polymeric chemical platforms for oligonucleotide microarray preparation. Nucleosides Nucleotides Nucleic Acids 21: 561–580. Keine Evaluation von Testverfahren

    Article  CAS  PubMed  Google Scholar 

  • Cotton R-GH, Knight MA, Southey M et al. (1996) A comparative study between enzyme mismatch cleavage (EMC) and direct sequencing to detect for mutations within the BRCA1 gene. Am J Hum Genet 59(Suppl. 4): A254. Keine Studie

    Google Scholar 

  • De Benedetti VM, Radice P, Mondini P et al. (1996) Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test. Oncogene 13: 1353–1357. Kein (vollständiger) Vergleich mit Referenztest

    PubMed  Google Scholar 

  • De la Hoya M, Diaz RE, Caldes T. (1999) Denaturing gradient gel electrophoresis-based analysis of loss of heterozygosity distinguishes nonobvious, deleterious BRCA1 variants from nonpathogenic polymorphisms. Clin Chem. 45: 11–2030. Kein (vollständiger) Vergleich mit Referenztest

    Google Scholar 

  • Elling D, Spitzer E, Potschick K, Krocker J, Grosse R. (2000) A two-stage test to identify BRCA-1 and BRCA-2 mutations in high-risk families. Geburtshilfe Frauenheilkd. 60: 6–332. Kein (vollständiger) Vergleich mit Referenztest

    Google Scholar 

  • Esteban-Cardenosa E, Duran M, Infante M, Velasco E, Miner C. (2004) High-throughput mutation detection method to scan BRCA1 and BRCA2 based on heteroduplex analysis by capillary array electrophoresis. Clin Chem 50: 313–320. Kein (vollständiger) Vergleich mit Referenztest

    CAS  PubMed  Google Scholar 

  • Evans DG, Bulman M, Young K, Gokhale D, Lalloo F. (2003) Sensitivity of BRCA1/2 mutation testing in 466 breast/ovarian cancer families. J Med Genet 40: e107. Keine Evaluation von Testverfahren

    Article  CAS  PubMed  Google Scholar 

  • Favis R, Barany F. (2000) Mutation detection in K-ras, BRCA1, BRCA2, and p53 using PCR/LDR and a universal DNA microarray. [Review] [13 refs]. Ann N Y Acad Sci 906: 39–43. Keine Studie

    CAS  PubMed  Google Scholar 

  • Favis R, Day JP, Gerry NP, Phelan C, Narod S, Barany F. (2000) Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat Biotechnol 18: 561–564. Nur einzelne Mutationen

    CAS  PubMed  Google Scholar 

  • Frolov A, Prowse AH, Vanderveer L, Bove B, Wu H, Godwin AK. (2002) DNA array-based method for detection of large rearrangements in the BRCA1 gene. [see comment]. Genes Chromosomes Cancer 35: 232–241. Große Sequenzrearrangements

    Article  CAS  PubMed  Google Scholar 

  • Gad S, Aurias A, Puget N, Mairal A et al. (2001) Color bar coding the BRCA1 gene on combed DNA: a useful strategy for detecting large gene rearrangements. Genes Chromosomes Cancer 31: 75–84. Große Sequenzrearrangements

    Article  CAS  PubMed  Google Scholar 

  • Gad S, Caux-Moncoutier V, Pages-Berhouet S et al. (2002) Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 21: 6841–6847. Große Sequenzrearrangements

    Article  CAS  PubMed  Google Scholar 

  • Gad S, Klinger M, Caux M et al. (2002) Bar code screening on combed DNA for large rearrangements of the BRCA1 and BRCA2 genes in French breast cancer families [3]. J Med Genet. 39: 11–821. Große Sequenzrearrangements

    Article  Google Scholar 

  • Gad S, Scheuner MT, Pages-Berhouet et al. (2001) Identification of a large rearrangement of the BRCA1 gene using colour bar code on combed DNA in an American breast/ovarian cancer family previously studied by direct sequencing. J Med Genet 38: 388–392. Große Sequenzrearrangements

    Article  CAS  PubMed  Google Scholar 

  • Garvin AM. (1998) A complete protein truncation test for BRCA1 and BRCA2. EUR J HUM GENET 6: 226–234. Keine Kontrollgruppe

    Article  CAS  PubMed  Google Scholar 

  • Garvin AM, Attenhofer-Haner M, Scott RJ. (1997) BRCA1 and BRCA2 mutation analysis in 86 early onset breast/ovarian cancer patients. J 34: 990–995. Kein (vollständiger) Vergleich mit Referenztest

    CAS  Google Scholar 

  • Garvin AM, Muller H, Scott-Rodney-J (1996) A protein truncation test for BRCA1. In: Mueller, H Scott-R-J Hereditary cancer: 2nd Int. Res. Conf. On Familial Cancer, Basel 1995. Karger, Basel Keine Studie

    Google Scholar 

  • Gayther SA, Harrington P, Russell P, Kharkevich G, Garkavtseva RF, Ponder BA. (1996) Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group. Am J Hum Genet 58: 451–456. Kein (vollständiger) Vergleich mit Referenztest

    CAS  PubMed  Google Scholar 

  • Geisler JP, Hatterman-Zogg MA, Rathe JA, Lallas TA, Kirby P, Buller RE. (2001) Ovarian cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms single strand conformation polymorphism analysis (SSCP). Hum Mutat 18: 337–344. Kein (vollständiger) Vergleich mit Referenztest

    Article  CAS  PubMed  Google Scholar 

  • Gite S, Lim M, Carlson R, Olejnik J, Zehnbauer B, Rothschild K. (2003) A high-throughput nonisotopic protein truncation test. Nat Biotechnol 21: 194–197. Nicht BRCA-Gen

    Article  CAS  PubMed  Google Scholar 

  • Gross E, Arnold N, Pfeifer K, Bandick K, Kiechle M. (2000) Identification of specific BRCA1 and BRCA2 variants by DHPLC. Hum Mutat 16: 345–353. Kein (vollständiger) Vergleich mit Referenztest

    Article  CAS  PubMed  Google Scholar 

  • Hacia JG, Brody LC, Chee MS, Fodor SP, Collins FS. (1996) Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. [see comment]. Nat Genet 14: 441–447. Chip-Technologie

    Article  CAS  PubMed  Google Scholar 

  • Hacia JG, Edgemon K, Fang N et al. (2000) Oligonucleotide microarray based detection of repetitive sequence changes. Hum Mutat 16: 354–363. Chip-Technologie

    Article  CAS  PubMed  Google Scholar 

  • Hacia JG, Edgemon K, Sun B, Stern D, Fodor SP, Collins FS. (1998) Two color hybridization analysis using high density oligonucleotide arrays and energy transfer dyes. Nucleic Acids Res 26: 3865–3866. Chip-Technologie

    CAS  PubMed  Google Scholar 

  • Hacia JG, Makalowski W, Edgemon K et al. (1998). Evolutionary sequence comparisons using high-density oligonucleotide arrays. Nat Genet 18: 155–158. Chip-Technologie

    Article  CAS  PubMed  Google Scholar 

  • Hacia JG, Woski SA, Fidanza J et al. (1998) Enhanced high density oligonucleotide array-based sequence analysis using modified nucleoside triphosphates. Nucleic Acids Res 26: 4975–4982. Chip-Technologie

    CAS  PubMed  Google Scholar 

  • Hatch A, Sano T, Misasi J, Smith CL. (1999) Rolling circle amplification of DNA immobilized on solid surfaces and its application to multiplex mutation detection. Genet Anal 15: 35–40. Nur einzelne Mutationen

    CAS  PubMed  Google Scholar 

  • Hawkins GA, Hoffman LM. (1997) Base excision sequence scanning. Nat Biotechnol 15: 803–804. Keine Evaluation von Testverfahren

    Article  CAS  PubMed  Google Scholar 

  • Hawkins GA, Hoffman LM. (1999) Rapid DNA mutation identification and fingerprinting using base excision sequence scanning. Electrophoresis 20: 1171–1176. Nur einzelne Mutationen

    Article  CAS  PubMed  Google Scholar 

  • Hegde MR, Chong B, Fawkner MJ et al. (2000) Hierarchical mutation screening protocol for the BRCA1 gene. Hum Mutat 16: 422–430. Kein (vollständiger) Vergleich mit Referenztest

    Article  CAS  PubMed  Google Scholar 

  • Hennessy LK, Teare J, Ko C. (1998) PCR conditions and DNA denaturants affect reproducibility of singlestrand conformation polymorphism patterns for BRCA1 mutations. Clin Chem 44: 879–882. Nur einzelne Mutationen

    CAS  PubMed  Google Scholar 

  • Herzog JS, Jancis EM, Liao S, Somlo G, Weitzel JN. (2002) Restriction endonuclease fingerprinting enhanced conformation sensitive gel electrophoresis (REF-CSGE) in the analysis of BRCA1 exon 11 mutations in a high-risk breast cancer cohort. Hum Mutat 19: 656–663. Kein (vollständiger) Vergleich mit Referenztest

    Article  CAS  PubMed  Google Scholar 

  • Hofmann W, Gorgens H, John A et al. (2003) Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi-quantitative multiplex PCR method. Hum Mutat 22: 103–104. Große Sequenzrearrangements

    Article  PubMed  Google Scholar 

  • Hogervorst FB, Cornelis RS, Bout M et al. (1995) Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet 10: 208–212. Kein (vollständiger) Vergleich mit Referenztest

    CAS  PubMed  Google Scholar 

  • Huang J, Kirk B, Favis R et al. (2002) An endonuclease/ligase based mutation scanning method especially suited for analysis of neoplastic tissue. Oncogene 21: 1909–1921. Kein (vollständiger) Vergleich mit Referenztest

    CAS  PubMed  Google Scholar 

  • Humphrey JS, Salim A, Erdos MR, Collins FS, Brody LC, Klausner RD. (1997) Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing. Proc Natl Acad Sci U S A 94(11): 5820–5825. Artifiziell erzeugte Sequenzen

    Article  CAS  PubMed  Google Scholar 

  • Ishioka C, Suzuki T, FitzGerald M et al. (1997) Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast. Proc Natl Acad Sci U S A 94: 2449–2453. Kein (vollständiger Vergleich) mit Referenztest

    Article  CAS  PubMed  Google Scholar 

  • Janatova M, Pohlreich P, Matous B. (2003) Detection of the most frequent mutations in BRCA1 gene on polyacrylamide gels containing Spreadex Polymer NAB. Neoplasma 50(4): 246–250. Nur einzelne Mutationen

    CAS  PubMed  Google Scholar 

  • Jugessur A, Frost P, Andersen TI et al. (2000) Enhanced detection of mutations in BRCA1 exon 11 using restriction endonuclease fingerprinting-single-strand conformation polymorphism. J Mol Med 78: 580–587. Kein (vollständiger) Vergleich mit Referenztest

    Article  CAS  PubMed  Google Scholar 

  • Kainu T, Kononen J, Johansson O, Olsson H, Borg A, Isola J. (1996) Detection of germline BRCA1 mutations in breast cancer patients by quantitative messenger RNA in situ hybridization. Cancer Res 56(13): 2912–2915. Kein (vollständiger) Vergleich mit Referenztest

    CAS  PubMed  Google Scholar 

  • Kataoka A, Tada M, Yano M et al. (2001) Development of a yeast stop codon assay readily and generally applicable to human genes. Am J Pathol 159: 1239–1245. Kein (vollständiger) Vergleich mit Referenztest

    CAS  PubMed  Google Scholar 

  • Kennedy RQ. (2003) Genetic testing for BRCA1 mutation in the UK. Lancet 361(9352): 179. Keine Studie

    Article  Google Scholar 

  • Kozlowski P, Sobczak K, Napierala M et al. (1996) PCR-SSCP-HDX analysis of pooled DNA for more rapid detection of germline mutations in large genes. The BRCA1 example. Nucleic Acids Res 24: 1177–1178. Keine Kontrollgruppe

    Article  CAS  PubMed  Google Scholar 

  • Kulinski J, Besack D, Oleykowski CA, Godwin AK, Yeung AT. (1948) CEL I enzymatic mutation detection assay. Biotechniques 29: 44–46. Keine Studie

    Google Scholar 

  • Kuperstein G, Foulkes WD, Ghadirian P, Hakimi J, Narod SA. (2000) A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes. Clin Genet 57: 213–220. Nur einzelne Mutationen

    Article  CAS  PubMed  Google Scholar 

  • Kuus RK, Knott CL, Payne J et al. (1999) Simple immunoassays for the detection of BRCA1 in cells. J Clin Ligand Assay 22: 4–347. Tierversuch

    Google Scholar 

  • Lallas TA, Buller RE. (1998) Optimization of PCR and electrophoresis conditions enhances mutation analysis of the BRCA1 gene. Mol Genet Metab 64: 173–176. Kein (vollständiger) Vergleich mit Referenztest

    Article  CAS  PubMed  Google Scholar 

  • Lancaster JM, Berchuck A, Futreal PA, Wiseman RW. (1997) Dideoxy fingerprinting assay for BRCA1 mutation analysis. Mol Carcinog 19: 176–179. Keine Kontrollgruppe

    Article  CAS  PubMed  Google Scholar 

  • Lancaster JM, Cochran CJ, Brownlee HA et al. (1996) Detection of BRCA1 mutations in women with earlyonset ovarian cancer by use of the protein truncation test. J Natl Cancer Inst. 88: 552–554. Kein (vollständiger) Vegleich mit Referenztest

    CAS  PubMed  Google Scholar 

  • Langston AA. BRCA1 mutations in population-based sample of young women with breast cancer. N Engl J Med 334(3): 137–142. Keine Evaluation von Testverfahren

    Google Scholar 

  • Langston AA, Stanford JL, Wicklund KG, Thompson JD, Blazej RG, Ostrander EA. (1996) Germ-line BRCA1 mutations in selected men with prostate cancer. Am J Hum Genet 58: 881–884. Keine Evaluation von Testverfahren

    CAS  PubMed  Google Scholar 

  • Lidereau R, Eisinger F, Champeme MH et al. (2000) Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer. Cancer Res 60: 1206–1210. Kein (vollständiger) Vergleich mit Referenztest

    CAS  PubMed  Google Scholar 

  • Lynch HT, Lemon SJ, Durham C et al. (1997) A descriptive study of BRCA1 testing and reactions to disclosure of test results. [see comment]. Cancer 79: 2219–2228. Keine Evaluation von Testverfahren

    CAS  PubMed  Google Scholar 

  • Mansukhani MM, Nastiuk KL, Hibshoosh H, Kularatne P, Russo D, Krolewski JJ (1997) Convenient, nonradioactive, heteroduplex-based methods for identifying recurrent mutations in the BRCA1 and BRCA2 genes. Diagn Mol Pathol 6: 229–237. Nur einzelne Mutationen

    CAS  PubMed  Google Scholar 

  • Markoff A, Savov A, Vladimirov V, Bogdanova N, Kremensky I, Ganev V. (1997) Optimization of singlestrand conformation polymorphism analysis in the presence of polyethylene glycol. [erratum appears in Clin Chem 1997 Apr;43(4):692]. Clin Chem 43: 30–33. Keine Kontrollgruppe

    CAS  PubMed  Google Scholar 

  • Markoff A, Sormbroen H, Bogdanova N et al. (1998). Comparison of conformation-sensitive gel electrophoresis and single-strand conformation polymorphism analysis for detection of mutations in the BRCA1 gene using optimized conformation analysis protocols. Eur J Hum Genet 6: 145–150. Kein (vollständiger) Vergleich mit Referenztest

    Article  CAS  PubMed  Google Scholar 

  • McGrath SB, Bounpheng M, Torres L et al. (2001) High-speed, multicolor fluorescent two-dimensional gene scanning. Genomics 78: 83–90. Keine Evaluation von Testverfahren

    Article  CAS  PubMed  Google Scholar 

  • Mironov N, Jansen LA, Zhu WB, Aguelon AM, Reguer G, Yamasaki H. (1999) A novel sensitive method to detect frameshift mutations in exonic repeat sequences of cancer-related genes. Carcinogenesis 20: 2189–2192. Keine Kontrollgruppe

    Article  CAS  PubMed  Google Scholar 

  • Monastiri K, Ben Ahmed S, Presneau N, Bignon JY, Chouchane L. (2002) [Rapid detection of BRCA-1 germline mutations by the protein truncation test in Tunisian families]. [French]. Tunis Med 80: 515–518. Kein (vollständiger) Vergleich mit Referenztest

    PubMed  Google Scholar 

  • Montagna M, Agata S, De Nicolo A et al. (2002) Identification of BRCA1 and BRCA2 carriers by allelespecific gene expression (AGE) analysis. Int Nat J Cancer 98: 732–736. Kein (vollständiger) Vergleich mit Referenztest

    CAS  Google Scholar 

  • Monteiro ANA, Humphrey JS. (1998) Yeast-based assays for detection and characterization of mutations in BRCA1. BREAST DIS 1961; Breast-Disease. 10: 1–2. Keine Evaluation von Testverfahren

    Google Scholar 

  • Moslehi R, Kariminejad MH, Ghafari V, Narod S. (2003) Analysis of BRCA1 and BRCA2 mutations in an Iranian family with hereditary breast and ovarian cancer syndrome. Am J Med Genet 117A: 304–305. Keine Studie

    Article  Google Scholar 

  • Oberacher H, Huber CG, Oefner PJ. (2003) Mutation scanning by ion-pair reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry (ICEMS). Hum Mutat 21: 86–95. Nur einzelne Mutationen

    Article  CAS  PubMed  Google Scholar 

  • Oldenburg SJ, Genick CC, Clark KA, Schultz DA. (2002) Base pair mismatch recognition using plasmon resonant particle labels. Anal Biochem 309: 109–116. Kein (vollständiger) Vergleich mit Referenztest

    Article  CAS  PubMed  Google Scholar 

  • Oleykowski CA, Bronson Mullins CR, Godwin AK, Yeung AT. (1998) Mutation detection using a novel plant endonuclease. Nucleic Acids Res 26: 4597–4602. Kein (vollständiger) Vergleich mit Referenztest

    Article  CAS  PubMed  Google Scholar 

  • Orban TI, Csokay B, Olah E. (2000) Sequence alterations can mask each other’s presence during screening with SSCP or heteroduplex analysis: BRCA genes as examples. Biotechniques 29: 94–98. Kein (vollständiger) Vergleich mit Referenztest

    CAS  PubMed  Google Scholar 

  • Ozcelik H, Antebi YJ, Cole DE, Andrulis IL. (1996) Heteroduplex and protein truncation analysis of the BRCA1 185delAG mutation. Hum Genet 98: 310–312. Nur einzelne Mutationen

    Article  CAS  PubMed  Google Scholar 

  • Pals G, Pindolia K, Worsham MJ. (1999) A rapid and sensitive approach to mutation detection using real-time polymerase chain reaction and melting curve analyses, using BRCA1 as an example. Mol Diagn 4: 241–246. Nur einzelne Mutationen

    CAS  PubMed  Google Scholar 

  • Payne SR, Newman B, King MC. (2000) Complex germline rearrangement of BRCA1 associated with breast and ovarian cancer. Genes Chromosomes Cancer 29: 58–62. Große Sequenzrearrangements

    Article  CAS  PubMed  Google Scholar 

  • Peelen T, van Vliet M, Bosch A et al. (2000) Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families. Br J Cancer 82(1): 151–156. Keine Evaluation von Testverfahren

    Article  CAS  PubMed  Google Scholar 

  • Pfeiffer RM, Bura E, Smith A, Rutter JL. (2002) Two approaches to mutation detection based on functional data. Stat Med 21: 3447–3464. Keine Evaluation von Testverfahren

    Article  PubMed  Google Scholar 

  • Plaschke J, Voss H, Hahn M, Ansorge W, Schackert HK. (1998) Doublex sequencing in molecular diagnosis of hereditary diseases. Biotechniques 24: 838–841. Nur einzelne Mutationen

    CAS  PubMed  Google Scholar 

  • Plummer SJ, Anton-Culver H, Webster L et al. (1995) Detection of BRCA1 mutations by the protein truncation test. Hum Mol Genet 4: 1989–1991. Kein (vollständiger) Vergleich mit Referenztest

    CAS  PubMed  Google Scholar 

  • Puget N, Stoppa-Lyonnet D, Sinilnikova OM et al. (1999) Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res 59(2): 455–461. Große Sequenzrearrangements

    CAS  PubMed  Google Scholar 

  • Ramus SJ, Kote-Jarai Z, Friedman LS et al. (1997) Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer. Am J Hum Genet 60: 1242–1246. Keine Evaluation von Testverfahren

    CAS  PubMed  Google Scholar 

  • Ricevuto E, Sobol H, Stoppa-Lyonnet D et al. (2001) Diagnostic strategy for analytical scanning of BRCA1 gene by fluorescence-assisted mismatch analysis using large, bifluorescently labeled amplicons. CLIN CANCER RES 7: 1638–1646. Kein (vollständiger) Vergleich mit Referenztest

    CAS  PubMed  Google Scholar 

  • Robinson MD, Chu CE, Turner G, Bishop DT, Taylor GR. (2000) Exon deletions and duplications in BRCA1 detected by semiquantitative PCR. Genet Test 4: 49–54. Große Genrearrangements

    Article  CAS  PubMed  Google Scholar 

  • Rohlfs EM, Heim RA, Couch FJ, Weber BL, Silverman LM. (1996) Detection of truncating mutations in BRCA1 by a protein truncation test. Am J Hum Genet 59(Suppl. 4): A283. Nur einzelne Mutationen

    Google Scholar 

  • Rohlfs EM, Learning WG, Friedman KJ, Couch FJ, Weber BL, Silverman LM. (1997) Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis. [see comment]. Clin Chem 43: 24–29. Keine Studie

    CAS  PubMed  Google Scholar 

  • Ross DW. (1997) BRCA1: Genetic testing and hereditary breast and ovarian cancer. Arch Pathol Lab Med 1997;. Arch Pathol Lab Med 121: 7–755. Keine Studie

    Google Scholar 

  • Rozycka M, Collins N, Stratton MR, Wooster R. (2000) Rapid detection of DNA sequence variants by conformation-sensitive capillary electrophoresis. Genomics 70: 34–40. Nur einzelne Mutationen

    Article  CAS  PubMed  Google Scholar 

  • Ruparel H, Ulz ME, Kim S, Ju J. (2004) Digital detection of genetic mutations using SPC-sequencing. Genome Res 14: 296–300. Nur einzelne Mutationen

    Article  CAS  PubMed  Google Scholar 

  • Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30: e57. Große Sequenzrearrangements

    Article  PubMed  Google Scholar 

  • Shuber AP, Michalowsky LA, Nass GS et al. (1997) High throughput parallel analysis of hundreds of patient samples for more than 100 mutations in multiple disease genes. Hum Mol Genet 6: 337–347. Keine Kontrollgruppe

    Article  CAS  PubMed  Google Scholar 

  • Spitzer E, Abbaszadegan MR, Schmidt F et al. (2000) Detection of BRCA1 and BRCA2 mutations in breast cancer families by a comprehensive two-stage screening procedure. Int J Cancer 85: 474–481. Kein (vollständiger) Vergleich mit Referenztest

    Article  CAS  PubMed  Google Scholar 

  • Tian H, Brody LC, Fan S, Huang Z, Landers JP. (2001) Capillary and microchip electrophoresis for rapid detection of known mutations by combining allele-specific DNA amplification with heteroduplex analysis. Clin Chem 47: 173–185. Nur einzelne Mutationen

    CAS  PubMed  Google Scholar 

  • Tian H, Brody LC, Landers JP. (2000) Rapid detection of deletion, insertion, and substitution mutations via heteroduplex analysis using capillary-and microchip-based electrophoresis. Genome Res 10: 1403–1413. Nur einzelne Mutationen

    Article  CAS  PubMed  Google Scholar 

  • Tian-H, Jaquins-Gerstl-A, Munro-N, Trucco-M, Brody-LC, Landers-JP (2000): Single-strand conformation polymorphism analysis by capillary and microchip electrophoresis: A fast, simple method for detection of common mutations in BRCA1 and BRCA2. Genomics 63: 25–34. Nur einzelne Mutationen

    Article  CAS  PubMed  Google Scholar 

  • Tonisson N, Kurg A, Kaasik K, Lohmussaar E, Metspalu A. (2000) Unravelling genetic data by arrayed primer extension. Clin Chem Lab Med 38: 165–170. Keine Kontrollgruppe

    Article  CAS  PubMed  Google Scholar 

  • Unger MA, Nathanson KL, Calzone K et al. (2000). Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet 67: 841–850. Große Sequenzrearrangements

    Article  CAS  PubMed  Google Scholar 

  • Van Orsouw NJ, Dhanda RK, Elhaji Y et al. (1999) A highly accurate, low cost test for BRCA1 mutations. J Med Genet 36: 747–753. Kein (vollständiger) Vergleich mit Referenztest

    PubMed  Google Scholar 

  • Van Orsouw NJ, Dhanda RK, Rines RD et al. (1998) Rapid design of denaturing gradient-based twodimensional electrophoretic gene mutational scanning tests. Nucleic Acids Res 26: 2398–2406. Keine Evaluation von Testverfahren

    PubMed  Google Scholar 

  • Van Orsouw NJ, Vijg J. (1999) Design and application of 2-D DGGE-based gene mutational scanning tests. Genet Anal 14(5–6): 205–213. Keine Evaluation von Testverfahren

    PubMed  Google Scholar 

  • Vijg J, Van Orsouw NJ. (1999) Two-dimensional gene scanning: exploring human genetic variability. [Review] [31 refs]. Electrophoresis 20: 1239–1249. Keine Evaluation von Testverfahren

    Article  CAS  PubMed  Google Scholar 

  • Wagner T, Stoppa-Lyonnet D, Fleischmann E et al. (1999) Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics 62: 369–376. Keine Verblindung

    Article  CAS  PubMed  Google Scholar 

  • Whitcombe D, Brownie J, Gillard HL et al. (1998) A homogeneous fluorescence assay for PCR amplicons: its application to real-time, single-tube genotyping. Clin Chem 44: 918–923. Kein (vollständiger) Vergleich mit Referenztest

    CAS  PubMed  Google Scholar 

  • Wong C, DiCioccio RA, Allen HJ, Werness BA, Piver MS. (1998) Mutations in BRCA1 from fixed, paraffinembedded tissue can be artifacts of preservation. Cancer Genet Cytogenet 107(1): 21–27. Keine Evaluation von Testverfahren

    Article  CAS  PubMed  Google Scholar 

  • Zelada-Hedman M, Wasteson AB, Claro A et al. (1997) A screening for BRCA1 mutations in breast and breastovarian cancer families from the Stockholm region. Cancer Res 57: 2474–2477. Keine Evaluation von Testverfahren

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Epidemiologie, Sozialmedizin und Gesundheitssystemforschung, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover

    Henriette Schleberger MPH (Ärztin) & Ansgar Gerhardus M.A. (Dr. med.)

  2. Abteilung für Zell- und Molekularpathologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover

    Dorothea Gadzicki (Dr. med.) & Brigitte Schlegelberger (Prof. Dr. med.)

  3. Institut für Gesundheits- und Medizinrecht, Universität Bremen, FB 6, Postfach 33 04 40, 28334, Bremen

    Ansgar Gerhardus M.A. (Dr. med.)

Authors
  1. Henriette Schleberger MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dorothea Gadzicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brigitte Schlegelberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ansgar Gerhardus M.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung Epidemiologie, Sozialmedizin und Gesundheitssystemforschung, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover

    Ansgar Gerhardus M.A. , Henriette Schleberger MPH (Ärztin) & Friedrich Wilhelm Schwartz ,  (Ärztin) & 

  2. Abteilung für Zell- und Molekularpathologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover

    Brigitte Schlegelberger

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Schleberger, H., Gadzicki, D., Schlegelberger, B., Gerhardus, A. (2005). Systematischer Vergleich der Testverfahren. In: Gerhardus, A., Schleberger, H., Schlegelberger, B., Schwartz, F.W. (eds) BRCA — Erblicher Brust- und Eierstockkrebs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26553-8_3

Download citation

  • DOI: https://doi.org/10.1007/3-540-26553-8_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-24441-7

  • Online ISBN: 978-3-540-26553-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation